JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc.
Loyola University
University College, London
National Taiwan University Hospital
University of Erlangen-Nürnberg Medical School
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Office of Rare Diseases (ORD)
National Cancer Institute (NCI)